Expertise in
1
conditions

Chongrui Xu

Guangzhou, CN 
Expertise in
1
conditions
Guangzhou, CN 

Overview

Chongrui Xu practices practicing medicine in Guangzhou, China.

Xu is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Esophageal Cancer, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and EGFR Positive Lung Cancer.

They are actively involved in clinical research, co-authoring 12 peer reviewed articles and participating in 1 clinical trial.

Locations

Guangzhou, 510080, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Randomized, Open-label, Controlled Multicenter Study to Compare Bevacizumab in Combination With Erlotinib Versus Erlotinib Alone in Chinese NSCLC Patients Harbouring Activating EGFR Mutations(Artemis)
Randomized, Open-label, Controlled Multicenter Study to Compare Bevacizumab in Combination With Erlotinib Versus Erlotinib Alone in Chinese NSCLC Patients Harbouring Activating EGFR Mutations(Artemis)
Enrollment Status: Completed
Publish Date: March 13, 2026
Intervention Type: Drug
Study Drugs: Bevacizumab, Erlotinib
Study Phase: Phase 3

12 Total Publications

Efficacy and toxicity of maintenance therapy with PD-1/PD-L1 inhibitors plus pemetrexed vs . immunotherapy alone for stage III/IV non-squamous non-small cell lung cancer: A real-world study.
Efficacy and toxicity of maintenance therapy with PD-1/PD-L1 inhibitors plus pemetrexed vs . immunotherapy alone for stage III/IV non-squamous non-small cell lung cancer: A real-world study.
Journal: Chinese medical journal
Published: September 29, 2025

Frequently Asked Questions about Chongrui Xu

Is Chongrui Xu a top-rated expert for Esophageal Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Chongrui Xu is classified as an Advanced expert for Esophageal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Chongrui Xu participate in research or clinical trials?

Yes. Chongrui Xu has published 12 articles and abstracts on conditions like Esophageal Cancer. You can view a list of Chongrui Xu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Xu's expertise for a condition
ConditionClose
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile